Literature DB >> 3548820

Structure of the complex group-specific polysaccharide of group B Streptococcus.

F Michon, E Katzenellenbogen, D L Kasper, H J Jennings.   

Abstract

The group-specific antigen was isolated from a type Ia group B streptococcal strain and is a complex polysaccharide composed of alpha-L-rhamnopyranosyl, alpha-D-galactopyranosyl, 2-acetamido-2-deoxy-beta-D-glucopyranosyl, D-glucitol, and phosphate residues. The complexity of the group B polysaccharide antigen is evident from the fact that when depolymerized by basic hydrolysis it yielded three structurally related, but nevertheless significantly different, oligosaccharides. These oligosaccharides were obtained in different molar quantities as their monophosphate esters. This evidence strongly suggests that they are linked by phosphodiester bonds in the original group B antigen. If these oligosaccharides are in fact randomly situated throughout the linear polysaccharide, then this type of heterogeneous repeating unit is unusual for a polysaccharide of bacterial origin. However, this structural arrangement of the oligosaccharides has yet to be unambiguously established because the alternate explanation of there being three different polysaccharides in the group B antigen cannot be discounted in the evidence presented here. The oligosaccharides were enzymatically dephosphorylated, and the structures of two of the three oligosaccharides are (formula: see text) Despite their structural differences, the two oligosaccharides are related by the smaller being an integral part of the larger. In the structural analysis of the group B antigen, methylation analysis, periodate oxidation, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, fast atom bombardment mass spectrometry, and various specific chemical and enzymatic degradations were the principal methods used. Of particular interest was the use of an alpha-rhamnosidase to selectively degrade the larger oligosaccharide. This facilitated the assignment of signals in its 1H and 13C NMR spectra.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548820     DOI: 10.1021/bi00376a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Evidence for helical structure in a tetramer of α2-8 sialic acid: unveiling a structural antigen.

Authors:  Marcos D Battistel; Michael Shangold; Loc Trinh; Joseph Shiloach; Darón I Freedberg
Journal:  J Am Chem Soc       Date:  2012-06-22       Impact factor: 15.419

3.  Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors:  M S Edwards; M R Wessels; C J Baker
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

4.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Isolation of a coaggregation-inhibiting cell wall polysaccharide from Streptococcus sanguis H1.

Authors:  F J Cassels; J London
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

6.  Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Authors:  M B Marques; D L Kasper; A Shroff; F Michon; H J Jennings; M R Wessels
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Demonstration of circulating group B streptococcal immune complexes in neonates with meningitis.

Authors:  J G Vallejo; C J Baker; M S Edwards
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; W J Benedí; H J Jennings; F Michon; J L DiFabio; D L Kasper
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.